Wo Kang Sheng Invited to Participate in KGI Securities' Corporate Presentation for Institutional Investors
Wo Kang Sheng has been invited to attend the corporate briefing hosted by KGI Securities on June 29,… · 2026-06-24
和康生 News Releases
[HoKang Biotech] February 2026 Monthly Revenue: NT$0.48 Billion (YoY +20.9%)
HoKang Biotech (1783) announced its February 2026 revenue of NT$0.48 billion, achieving a year-on-ye… · 2026-02-01
[Maxigen Biotech] May 2026 Revenue Reaches NT$73.6 Million (Down 4.4% YoY)
Maxigen Biotech Inc. (code: 1783), a biotechnology and medical care company, announced its May 2026 … · 2026-05-01
[WAKANSE] Announcement of Important Resolutions from the Company's 2026 Annual General Meeting of Shareholders
WAKANSE announced that at its 2026 Annual General Meeting of Shareholders, it approved the profit di… · 2026-06-11
WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)
WAKANSE announced its revenue for March 2026, reaching 69.939 million yen (approximately 0.70 hundre… · 2026-03-01
【Hocance Biotech】Announcement of the Company's Q1 2026 Consolidated Financial Report Submitted to the Board of Directors
Hocance Biotech submitted its Q1 2026 consolidated financial report to the board. For the period fro… · 2026-04-28
【Hocheng】2026-04 Monthly Revenue NT$0.61 Billion (YoY +15.8%)
Hocheng (Company Code: 1783) announced its monthly revenue for April 2026 reached NT$61.27 million (… · 2026-04-01
【Hokang Bioengineering】Board of Directors Resolves Dividend Distribution
Hokang Bioengineering's Board of Directors resolved on April 28, 2026, to distribute a cash dividend… · 2026-04-28
【Hocance Biotech】Announcement of the Company's Q1 2026 Consolidated Financial Report Submitted to the Board of Directors
Hocance Biotech submitted its Q1 2026 consolidated financial report to the board. For the period fro… · 2026-04-28
[Winkon Biotechnology] Announcement of Scheduled Board Meeting Date for Q1 2026 Consolidated Financial Report
Winkon Biotechnology announced on April 20, 2026, that its board meeting is scheduled for April 28, … · 2026-04-20
[Winkon Biotechnology] Announcement of Scheduled Board Meeting Date for Q1 2026 Consolidated Financial Report
Winkon Biotechnology announced on April 20, 2026, that its board meeting is scheduled for April 28, … · 2026-04-20
WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)
WAKANSE announced its revenue for March 2026, reaching 69.939 million yen (approximately 0.70 hundre… · 2026-03-01
[HoKang Biotech] February 2026 Monthly Revenue: NT$0.48 Billion (YoY +20.9%)
HoKang Biotech (1783) announced its February 2026 revenue of NT$0.48 billion, achieving a year-on-ye… · 2026-02-01
【Hokang Bioengineering】Board of Directors Resolves Dividend Distribution
Hokang Bioengineering's Board of Directors resolved on April 28, 2026, to distribute a cash dividend… · 2026-04-28
【Hocheng】2026-04 Monthly Revenue NT$0.61 Billion (YoY +15.8%)
Hocheng (Company Code: 1783) announced its monthly revenue for April 2026 reached NT$61.27 million (… · 2026-04-01
【Hocason Biotech】Announcement of Change in Corporate Director's Representative and Change of Over One-Third of the Board of Directors
Hocason Biotech announced that its corporate director, TCI Co., Ltd., has reappointed its representa… · 2026-05-18
H&B Announces Change in Corporate Director Representative, Board Member Change Exceeds One-Third
H&B (Health & Beauty, 1783) announced a change in the representative for its corporate director, TCI… · 2026-05-18